Diabetologie und Stoffwechsel, Inhaltsverzeichnis Diabetologie und Stoffwechsel 2013; 8(2): R15-R30DOI: 10.1055/s-0033-1335249 DuS-Refresher © Georg Thieme Verlag KG Stuttgart · New YorkDiabetestherapie bei Kindern und Jugendlichen Autoren O. Kordonouri Artikel empfehlen Abstract Artikel einzeln kaufen(opens in new window) Volltext Referenzen Literatur 1 Danne T, Beyer P, Holl RW et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. In: Scherbaum WA, Kiess W, (Hrsg) Evidenzbasierte Diabetes-Leitlinie DDG. Diabetes Stoffwechsel 2004; 13 (Suppl 2) 2 Craig ME, Hattersley A, Donaghue K. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Definition, epidemiology and classification. Pediatr Diabetes 2006; 7: 343-351 3 Hattersley A, Bruining J, Shield J et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006; 7: 352-360 4 Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008; 371: 1777-1782 5 Neu A, Ehehalt S, Willasch A et al. Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age. Diabetes Care 2001; 24: 785-786 6 Rosenbauer J, Icks A, Schmitter D et al. Incidence of childhood Type I diabetes mellitus is increasing at all ages in Germany. Diabetologia 2002; 45: 457-158 7 Ehehalt S, Blumenstock G, Willasch AM et al. Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet Med 2008; 25: 755-757 8 Neu A, Willasch A, Ehehalt S et al. Prävalenz und Altersverteilung des Diabetes mellitus im Kindesalter in Deutschland. Monatsschr Kinderheilkd 2002; 150: 196-200 9 Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood type 1 diabetes mellitus in Germany – model-based national estimates. J Pediatr Endocrinol Metab 2002; 15: 1497-1504 10 Pinhas-Hamiel O, Zeitler P. The Global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005; 146: 693-700 11 Rosenbauer J, Icks A, du Prel JB et al. Populationsbasierte Daten zur Inzidenz des Typ-2-Diabetes mellitus bei Kindern und Jugendlichen in Deutschland. Monatsschr Kinderheilkd 2003; 151: 71 12 Neu A, Feldhahn L, Ehehalt S et al. Prevalence of type 2 diabetes and MODY in children and adolescents. A state-wide study in Baden-Wuerttemberg (Germany). Pediatr Diabetes 2005; 6: 27-28 13 Holl RW, Grabert M. Versorgung von Kindern und Jugendlichen mit Diabetes: Entwicklung der letzten 17 Jahre. Deutscher Gesundheitsbericht. Diabetes 2012; Kirchheim Verlag 2012, 131-140 14 Achenbach P, Pan L, Ziegler A-G. Pathogenese des Diabetes mellitus Typ 1. Diabetologie 2007; 2: R25-R39 15 Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188 16 White NH, Cleary PA, Dahms W et al. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial. J Pediatr 2001; 139: 804-812 17 Kapellen TM, Wolf J, Rosenbauer J et al. for the DPV-Science-Initiative Changes in the use of analogue insulins in 37,206 children and adolescents with type 1 diabetes in 275 German and Austrian centres during the last twelve years. Exp Clin Endocrinol Diabetes 2009; 117: 329-335 18 Kordonouri O, Danne T. Insulintherapie bei Kindern und Jugendlichen. Diabetologe 2008; 4: 499-505 19 Hürter P, Kordonouri O, Lange K et al. Kompendium pädiatrische Diabetologie. Heidelberg: Springer; 2006: 208-210 20 Dorchy H. Dietary management for children and adolescents with diabetes mellitus: personal experience and recommendations. J Pediatr Endocrinol Metab 2003; 16: 131-148 21 Holder M, Ludwig-Seibold C, Lilienthal E et al. für die DPV-Wiss-Initiative Trends in der Insulinpumpentherapie bei Kindern, Jugendlichen und jungen Erwachsenen mit Typ-1-Diabetes von 1995–2006: Daten der DPV-Initiative. Diabetologie 2007; 2: 169-174 22 Pańkowska E, Błazik M, Dziechciarz P et al. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009; 10: 52-58 23 Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012; 366: 1616-1624 24 Fox LA, Buckloh LM, Smith SD et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005; 28: 1277-1281 25 Holterhus PM, Odendahl R, Oesingmann S et al. German/Austrian DPV Initiative; German Pediatric CSII Working Group. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy. Diabetes Care 2007; 30: 568-573 26 Deiss D, Lauterborn R, Hartmann R et al. Teilambulantes Schulungsprogramm zur Insulinpumpentherapie für Kinder und Jugendliche mit Typ-1-Diabetes: Evaluierung von Stoffwechsel und Therapieverlauf. Diabetes Stoffwechsel 2004; 13: 91-97 27 Danne T, von Schütz W, Lange K et al. Current practice of insulin pump therapy in children and adolescents – the Hannover recipe. Pediatric Diabetes 2006; 7 (Suppl. 04) 25-31 28 Ziegler R, Heidtmann B, Hilgard D. DPV-Wiss-Initiative et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011; 12: 11-17 29 Tamborlane WV, Beck RW, Bode BW. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476 30 Deiss D, Bolinder J, Riveline JP et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006; 29: 2730-2732 31 Danne T, de Valk HW, Kracht T et al. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology. Diabetologia 2009; 52: 1496-1503 32 Phillip M, Danne T, Shalitin S et al. Consensus Forum Participants. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012; 13: 215-228 33 Hürter P, Jastram H-U, Regling B et al. Diabetes bei Kindern: ein Behandlungs- und Schulungsprogramm. Mainz: Kirchheim; 2005 34 Lange K, Burger W, Haller R et al. Jugendliche mit Diabetes – ein Schulungsprogramm. 2. Aufl. Mainz: Kirchheim; 2009 35 Rosenbloom AL, Silverstein JH, Amemiya S et al. ISPAD Clinical Practice Consensus Guideline 2006–2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 2008; 9: 512-526 36 American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381-389 37 Jones K, Arslanian S, McVie R et al. Metformin improves glycaemic control in children with type 2 diabetes. Diabetes Care 2002; 25: 89-94 38 Aschemeier B, Lange K, Kordonouri O et al. Paediatric obesity and type 2 diabetes – strategies for prevention and treatment. Practical Diabetes Int 2008; 25: 368-375 39 Ellard S, Bellanné-Chantelot C, Hattersley AT. European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51: 546-553 40 Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002; 39: 872-875 41 Edghill E, Flanagan SE, Patch AM et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008; 57: 1034-1042 42 Pearson ER, Flechtner I, Njolstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467-477 43 Danne T, Lange K, Kordonouri O. New developments in the treatment of type 1 diabetes in children. Arch Dis Child 2007; 92: 1015-1019